Clinician-guided cannabis care has the potential to relieve suffering at great scale and save billions in healthcare cost for those dealing with serious health challenges like cancer and chronic pain. Join us for a learning and AMA session on how to bring serious alternative care models to market in a landscape of:
- A wary healthcare ecosystem unprepared for this form of care integration and in need of treatment standards where none exist, irrespective of its widespread use among patients.
- A cannabis industry, emulating a consumer retail and social consumption model like alcohol, heavily focused on high-potency, combustible products wholly unsuitable for healthcare.
- A rapidly changing Federal regulatory environment playing catch up with the citizenry, but without the clinical outcomes and cost data due to Schedule One research embargoes.